Hyperbaric oxygen therapy for the treatment of children and youth with Autism Spectrum Disorders: An evidence-based systematic review / Cynthia GOLDFARB in Research in Autism Spectrum Disorders, 29-30 (September–October 2016)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 29-30 (September–October 2016) . - p.1-7 Titre : Hyperbaric oxygen therapy for the treatment of children and youth with Autism Spectrum Disorders: An evidence-based systematic review Type de document : Texte imprimé et/ou numérique Auteurs : Cynthia GOLDFARB, Auteur ; Lisa GENORE, Auteur ; Carolyn HUNT, Auteur ; Janine FLANAGAN, Auteur ; Mark HANDLEY-DERRY, Auteur ; Anita JETHWA, Auteur ; Nicola JONES-STOKREEF, Auteur ; S. M. L. KIRKPATRICK, Auteur ; A. RICHARDS, Auteur ; Lillian ROJNICA, Auteur ; Clive SCHWARTZ, Auteur ; David SHAWN, Auteur ; Diann SUPERINA-BELL, Auteur ; Elizabeth YOUNG, Auteur ; Evdokia ANAGNOSTOU, Auteur Article en page(s) : p.1-7 Langues : Anglais (eng) Mots-clés : Autism  Hyperbaric oxygen therapy  Treatment  Review Index. décimale : PER Périodiques Résumé : AbstractBackground Autism Spectrum Disorder (ASD) is a common disorder that has a complex and heterogeneous etiology. Some evidence suggests that inflammation and oxidative stress may have a pathophysiological link. Hyperbaric Oxygen Therapy (HBOT) has been proposed as a possible therapy. Because HBOT is an expensive treatment with significant commercial opportunity, it is essential for it to have a research evidence base prior to widespread use. Objective To conduct a systematic review of the literature evaluating the clinical impact of HBOT on behavior and development in ASD with a view to inform practice. Methods A literature search of electronic scientific databases focusing on clinical outcomes of HBOT in ASD was performed. Articles meeting inclusion criteria were independently assessed by reviewers and were classified according to the American Academy of Neurology Guidelines. Recommendations were made based on the evidence. Results Five articles were reviewed with data extraction. Based on the AAN Classification of Recommendations the data supported a rating of “A”, indicating that HBOT is not effective for treating children and youth with ASD. Conclusions Current evidence does not support HBOT as an effective treatment for children and youth with ASD. En ligne : http://dx.doi.org/10.1016/j.rasd.2016.05.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=292 [article] Hyperbaric oxygen therapy for the treatment of children and youth with Autism Spectrum Disorders: An evidence-based systematic review [Texte imprimé et/ou numérique] / Cynthia GOLDFARB, Auteur ; Lisa GENORE, Auteur ; Carolyn HUNT, Auteur ; Janine FLANAGAN, Auteur ; Mark HANDLEY-DERRY, Auteur ; Anita JETHWA, Auteur ; Nicola JONES-STOKREEF, Auteur ; S. M. L. KIRKPATRICK, Auteur ; A. RICHARDS, Auteur ; Lillian ROJNICA, Auteur ; Clive SCHWARTZ, Auteur ; David SHAWN, Auteur ; Diann SUPERINA-BELL, Auteur ; Elizabeth YOUNG, Auteur ; Evdokia ANAGNOSTOU, Auteur . - p.1-7. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 29-30 (September–October 2016) . - p.1-7 Mots-clés : Autism  Hyperbaric oxygen therapy  Treatment  Review Index. décimale : PER Périodiques Résumé : AbstractBackground Autism Spectrum Disorder (ASD) is a common disorder that has a complex and heterogeneous etiology. Some evidence suggests that inflammation and oxidative stress may have a pathophysiological link. Hyperbaric Oxygen Therapy (HBOT) has been proposed as a possible therapy. Because HBOT is an expensive treatment with significant commercial opportunity, it is essential for it to have a research evidence base prior to widespread use. Objective To conduct a systematic review of the literature evaluating the clinical impact of HBOT on behavior and development in ASD with a view to inform practice. Methods A literature search of electronic scientific databases focusing on clinical outcomes of HBOT in ASD was performed. Articles meeting inclusion criteria were independently assessed by reviewers and were classified according to the American Academy of Neurology Guidelines. Recommendations were made based on the evidence. Results Five articles were reviewed with data extraction. Based on the AAN Classification of Recommendations the data supported a rating of “A”, indicating that HBOT is not effective for treating children and youth with ASD. Conclusions Current evidence does not support HBOT as an effective treatment for children and youth with ASD. En ligne : http://dx.doi.org/10.1016/j.rasd.2016.05.004 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=292

---

1 (1 - 1 / 1)